Breakthrough infections and waning immune responses with ChAdOx1 nCoV-19 or mRNA vaccine in healthcare workers.

Lim, So Yun; Jung, Jiwon; Kim, Ji Yeun; Park, Soonju; Kwon, Ji-Soo; Park, So Yeon; Kim, Sun-Kyung; Lim, Young-Ju; Kim, Eun Ok; Bae, Seongman; Kim, Min Jae; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Lee, Nakyung; Kim, Kideok; Shum, David; Jee, Youngmee; Kim, Sung-Han

Lim, So Yun; Jung, Jiwon; Kim, Ji Yeun; Park, Soonju; Kwon, Ji-Soo; Park, So Yeon; Kim, Sun-Kyung; Lim, Young-Ju; Kim, Eun Ok; Bae, Seongman; Kim, Min Jae; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Lee, Nakyung; Kim, Kideok; Shum, David; Jee, Youngmee; Kim, Sung-Han.

Affiliation

Lim SY; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Jung J; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim JY; Office for Infection Control, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Park S; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kwon JS; Institut Pasteur Korea, Seongnam-si, Republic of Korea.
Park SY; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim SK; Office for Infection Control, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Lim YJ; Office for Infection Control, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Kim EO; Office for Infection Control, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Bae S; Office for Infection Control, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Kim MJ; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Chong YP; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee SO; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Choi SH; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim YS; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee N; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim K; Institut Pasteur Korea, Seongnam-si, Republic of Korea.
Shum D; Institut Pasteur Korea, Seongnam-si, Republic of Korea.
Jee Y; Institut Pasteur Korea, Seongnam-si, Republic of Korea.
Kim SH; Institut Pasteur Korea, Seongnam-si, Republic of Korea.

Clin Transl Med ; 12(4): e804, 2022 04.

Article de En | MEDLINE | ID: mdl-35452187

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins contre la COVID-19 / Vaccin ChAdOx1 nCoV-19 Limites: Humans Langue: En Journal: Clin Transl Med Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google